Heart failure hospitalisation (RR) · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Worsening heart failure · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Worsening kidney function · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypotension · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hyperkalaemia · heart failure with chronic kidney disease
CHRONIC: Aldosterone antagonists may leads to higher hyperkalaemia compared with placebo (low certainty).
1 finding from 1 review
Quality of life · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Heart failure hospitalisation (RR) · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Worsening heart failure · heart failure with chronic kidney disease
ACUTE: Serelaxin may leads to lower worsening heart failure compared with placebo (low certainty).
1 finding from 1 review
Worsening kidney function · heart failure with chronic kidney disease
ACUTE: Serelaxin showed no clear difference in worsening kidney function compared with placebo (low certainty).
1 finding from 1 review
Hypotension · heart failure with chronic kidney disease
ACUTE: Serelaxin showed no clear difference in hypotension compared with placebo (low certainty).
1 finding from 1 review
Hyperkalaemia · heart failure with chronic kidney disease
It is very uncertain whether ACUTE: Serelaxin changes hyperkalaemia compared with placebo (very low certainty).
1 finding from 1 review
Quality of life · heart failure with chronic kidney disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major bleeding · CRRT
Citrate probably leads to lower major bleeding compared with unfractionated heparin (moderate certainty).
1 finding from 1 review
Successful prevention of clotting · CRRT
It is very uncertain whether unfractionated heparin changes successful prevention of clotting compared with low molecular weight heparin (very low certainty).
1 finding from 1 review
Treatment cessation due to adverse events · CRRT
Unfractionated heparin showed no clear difference in treatment cessation due to adverse events compared with low molecular weight heparin (low certainty).
1 finding from 1 review
Recovery of kidney function · CRRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Thrombocytopenia · CRRT
It is very uncertain whether unfractionated heparin changes thrombocytopenia compared with low molecular weight heparin (very low certainty).
1 finding from 1 review
Cost to health care services · CRRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Major bleeding · CRRT
It is very uncertain whether unfractionated heparin changes major bleeding compared with no pharmacological anticoagulation (very low certainty).
1 finding from 1 review
Death at 28 days · CRRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found